According to Rajeev Gupta, director of internal medicine at CK Birl Hospital®, FLiRT, which belongs to Omicron's JN.1 lineage, is rapidly replacing the previous version, Aeris, in the US, UK, New Zealand and South Korea. , Delhi.
"The recent increase in hospitalization rates in these countries has been attributed to this variant; however, this remains a relatively small wave. The overall mortality rate has not increased," Gupta told IANS.
According to the Infectious Disease Society of America, the nickname 'FLiRT' is based on the technical names of their mutations.
The World Health Organization (WHO) has reclassified it as a variant of interest and advises close monitoring.
According to Dhiren Gupta, Pediatric Intensivist of Sir Ganga Ram Hospital, these new strains will continue to emerge.
He said, "Fortunately, none of the Omicron lineages are capable of causing significant moon damage like the Delta strain, but are limited to the upper respiratory tract. Surveillance and vigilance should be maintained for major drift in the virus."
According to experts, the increased use of monoclonal antibodies may increase this mutation.
The expert said the symptoms of the new variant are similar to other Omicro subvariants, such as sore throat, cough, fatigue, nasal congestion, runny nose, headache, muscle pain, fever and possible loss of taste and smell.
"The recent increase in hospitalization rates in these countries has been attributed to this variant; however, this remains a relatively small wave. The overall mortality rate has not increased," Gupta told IANS.
According to the Infectious Disease Society of America, the nickname 'FLiRT' is based on the technical names of their mutations.
The World Health Organization (WHO) has reclassified it as a variant of interest and advises close monitoring.
According to Dhiren Gupta, Pediatric Intensivist of Sir Ganga Ram Hospital, these new strains will continue to emerge.
He said, "Fortunately, none of the Omicron lineages are capable of causing significant moon damage like the Delta strain, but are limited to the upper respiratory tract. Surveillance and vigilance should be maintained for major drift in the virus."
According to experts, the increased use of monoclonal antibodies may increase this mutation.
The expert said the symptoms of the new variant are similar to other Omicro subvariants, such as sore throat, cough, fatigue, nasal congestion, runny nose, headache, muscle pain, fever and possible loss of taste and smell.
